Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/411863
Full metadata record
DC FieldValueLanguage
dc.coverage.spatial
dc.date.accessioned2022-10-12T05:21:13Z-
dc.date.available2022-10-12T05:21:13Z-
dc.identifier.urihttp://hdl.handle.net/10603/411863-
dc.description.abstractGlioblastoma (GBM) is the most aggressive brain tumor in adults. Resistance mechanisms in newlineGBM present an array of challenges to understand its biology and to develop novel therapeutic newlinestrategies. Despite multidisciplinary treatments, overall survival remains poor in glioma newlinepatients. Although novel therapeutic approaches are being explored, no outstanding effects on newlinethe survival of GBM patients have been achieved so far. This substantiates the need to develop newlinenew therapeutic strategies. Hence, understanding glioma biology and the mechanisms newlineresponsible for its high malignancy is of central importance. In this regard, we have examined newlinethe impact of the tumor suppressor gene (TSG) MTUS1, coding for ATIP1, in glioma newlinemalignancy as well as how its expression might influence GBM therapy. MTUS1 has been newlinereported as a TSG in various cancers but there are no reports in glioma. We found that ATIP1 newlinewas significantly downregulated in high-grade glioma (HGG), GBM cells and GSC. In glioma newlinecells, ATIP1 mitigates proliferation, clonogenic outgrowth and is accompanied by cell motility newlinereduction and can be used as a biological marker to predict therapy outcomes. Glioma newlinespecimens, GBM cells and glioma stem cells (GSC) were analysed for ATIP1 expression by newlinePCR, immunoblot and immunohistology. In order to analyse the role of MTUS1 promotermethylation, newlineDecitabine treatment and bisulfite sequencing (BSS) were used. We found that in newlineHGG, decitabine treatment results in enhanced expression of ATIP1 and promoter methylation newlinemight play a crucial role in MTUS1 downregulation. In glioma-bearing mice, ATIP1 prolonged newlinethe overall and median survival. The effect of temozolomide (TMZ) and tumor irradiation on newlineATIP1 expression and its influence on survival were examined in vitro and in vivo. TMZ newlinetreatment recovered ATIP1 expression both in vitro and in vivo. However, surprisingly, newlineincreased ATIP1 expression resulted in an increased repair of irradiation-induced DNA damage newlineand protects GBM cells against cell death induced by irradiation. The impact
dc.format.extent140p
dc.languageEnglish
dc.relation
dc.rightsuniversity
dc.titleRole of tumor suppressor MTUS1 ATIP1 in gliomagenesis Association with epigenetics and DNA repair
dc.title.alternative
dc.creator.researcherNikhil Ranjan
dc.subject.keywordBiotechnology and Applied Microbiology
dc.subject.keywordLife Sciences
dc.subject.keywordMicrobiology
dc.description.note
dc.contributor.guidePrakash Babu, P
dc.publisher.placeHyderabad
dc.publisher.universityUniversity of Hyderabad
dc.publisher.institutionDepartment of Biotechnology
dc.date.registered2015
dc.date.completed2021
dc.date.awarded2021
dc.format.dimensions
dc.format.accompanyingmaterialNone
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:Department of Biotechnology

Files in This Item:
File Description SizeFormat 
80_recommendation.pdfAttached File657.32 kBAdobe PDFView/Open
abbreviations.pdf103.01 kBAdobe PDFView/Open
abstract.pdf130.77 kBAdobe PDFView/Open
acknowledgement.pdf104.32 kBAdobe PDFView/Open
certificate.pdf323.44 kBAdobe PDFView/Open
chapter 1.pdf1.13 MBAdobe PDFView/Open
chapter 2.pdf247.59 kBAdobe PDFView/Open
chapter 3.pdf3.46 MBAdobe PDFView/Open
chapter 4.pdf4.92 MBAdobe PDFView/Open
chapter 5.pdf2.37 MBAdobe PDFView/Open
chapter 6.pdf1.84 MBAdobe PDFView/Open
conclusion.pdf603.67 kBAdobe PDFView/Open
contents.pdf151.26 kBAdobe PDFView/Open
declaration.pdf67.44 kBAdobe PDFView/Open
references.pdf204.56 kBAdobe PDFView/Open
title.pdf227.89 kBAdobe PDFView/Open


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: